Literature DB >> 8609043

The relationship between aryl hydrocarbon hydroxylase and polymorphisms of the CYP1A1 gene.

C Kiyohara1, T Hirohata, S Inutsuka.   

Abstract

We examined the relationship between aryl hydrocarbon hydroxylase (AHH) and the frequency of a MspI mutation in the 3'-flanking region of cytochrome P450 (CYP) 1A1 (MspI polymorphism) and another mutation in exon 7 (Ile-Val polymorphism) in 84 healthy male subjects in Fukuoka, Japan. AHH inducibility (3-methylcholanthrene (MC)-induced AHH activity/non-induced AHH activity) was correlated with the MspI polymorphism (P < 0.0001) and age class (P = 0.015), whereas no correlation was found for the Ile-Val polymorphism (P = 0.509). Age-adjusted AHH inducibility (mean +/- SE) of the predominant homozygote (genotype A), the heterozygote (genotype B) and a homozygote rare allele (genotype C) genotypes was 4.89 +/- 0.36, 4.82 +/- 0.29 and 13.61 +/- 1.44, respectively. The genotype C showed much higher AHH inducibility than genotypes A and B (P < 0.001), while no significant difference was observed between genotypes A and B. Non-induced AHH activity was also correlated with these polymorphisms. The AHH activity of a homozygous mutant Val/Val genotype (0.076 +/- 0.010 pmol/min/10(6) cells) was significantly higher (P < 0.05) than that of the wild-type homozygous Ile/Ile (0.044 +/- 0.004 pmol/min/10(6) cells) and heterozygous Ile/Val (0.047 +/- 0.007 pmol/min/10(6) cells) genotypes. Our study suggests that the genotypes C and Val/Val, which are more frequent in smoking-related lung cancer, are closely related with high AHH inducibility and high non-induced AHH activity, respectively. Thus, the positive relationship between AHH inducibility and lung cancer is supported by our study. If our results are confirmed and the assessment of genotype becomes feasible on a population basis, identification of smokers who have genetically high susceptibility to lung cancer (genotype C or Val/Val) may become important for the prevention of lung cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8609043      PMCID: PMC5920980          DOI: 10.1111/j.1349-7006.1996.tb00194.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  29 in total

1.  Aryl-hydrocarbon hydroxylase activity in lymphocytes from lung cancer patients and normal controls.

Authors:  H A Guirgis; H T Lynch; T Mate; R E Harris; I Wells; L Caha; J Anderson; K Maloney; L Rankin
Journal:  Oncology       Date:  1976       Impact factor: 2.935

2.  Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene.

Authors:  K Kawajiri; K Nakachi; K Imai; A Yoshii; N Shinoda; J Watanabe
Journal:  FEBS Lett       Date:  1990-04-09       Impact factor: 4.124

3.  Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose.

Authors:  K Nakachi; K Imai; S Hayashi; J Watanabe; K Kawajiri
Journal:  Cancer Res       Date:  1991-10-01       Impact factor: 12.701

4.  Distribution of aryl hydrocarbon hydroxylase inducibility in cultured human lymphocytes.

Authors:  B Paigen; J Minowada; H L Gurtoo; K Paigen; N B Parker; E Ward; N T Hayner; I D Bross; F Bock; R Vincent
Journal:  Cancer Res       Date:  1977-06       Impact factor: 12.701

Review 5.  Regulation of the mammalian cytochrome P1-450 (CYP1A1) gene.

Authors:  D W Nebert; J E Jones
Journal:  Int J Biochem       Date:  1989

6.  In vitro effects of methylsulfonyl polychlorinated biphenyls and 7,8-benzoflavone on aryl hydrocarbon hydroxylase activity in human lymphoblastoid cells.

Authors:  C Kiyohara; N Mohri; T Hirohata; K Haraguchi; Y Masuda
Journal:  Pharmacol Toxicol       Date:  1990-04

7.  Two RFLPs associated with the human P1450 gene linked to the MPI locus on chromosome 15 [HGM8 D15S8].

Authors:  A K Jaiswal; D W Nebert
Journal:  Nucleic Acids Res       Date:  1986-05-27       Impact factor: 16.971

8.  Relationships between aryl hydrocarbon hydroxylase inducibility and sensitivity to chemically induced subcutaneous sarcomas in various strains of mice.

Authors:  R E Kouri; R A Salerno; C E Whitmire
Journal:  J Natl Cancer Inst       Date:  1973-02       Impact factor: 13.506

9.  Genetic control of interindividual variations in the inducibility of aryl hydrocarbon hydroxylase in cultured human lymphocytes.

Authors:  S A Atlas; E S Vesell; D W Nebert
Journal:  Cancer Res       Date:  1976-12       Impact factor: 12.701

10.  Polycyclic aromatic hydrocarbon-DNA adducts and the CYP1A1 restriction fragment length polymorphism.

Authors:  P G Shields; H Sugimura; N E Caporaso; S F Petruzzelli; E D Bowman; B F Trump; A Weston; C C Harris
Journal:  Environ Health Perspect       Date:  1992-11       Impact factor: 9.031

View more
  15 in total

1.  Meta-analysis of the association of CYP1A1 polymorphisms with gastric cancer susceptibility and interaction with tobacco smoking.

Authors:  Fujun Han; Xinsheng Wang; Xuhui Wang; Yongfeng Luo; Wei Li
Journal:  Mol Biol Rep       Date:  2012-06-16       Impact factor: 2.316

2.  Genetic polymorphism of enzymes involved in xenobiotic metabolism and the risk of lung cancer.

Authors:  Chikako Kiyohara; Taro Shirakawa; Julian M Hopkin
Journal:  Environ Health Prev Med       Date:  2002-05       Impact factor: 3.674

3.  CYP1A1 and CYP2E1 genotypes and risk of esophageal squamous cell carcinoma in a high-incidence region, Kashmir.

Authors:  Gulzar Ahmad Bhat; Idrees Ayoub Shah; Muzamil Ashraf Makhdoomi; Beenish Iqbal; Rumaisa Rafiq; Sumaiya Nabi; Akbar Masood; Mohd Maqbool Lone; Nazir Ahmad Dar
Journal:  Tumour Biol       Date:  2014-02-08

4.  Glutathione S-transferases T1 null genotype is associated with susceptibility to aristolochic acid nephropathy.

Authors:  Bicheng Chen; Yongheng Bai; Mei Sun; Xiaojie Ni; Yunxiu Yang; Yirong Yang; Shaoling Zheng; Feifei Xu; Shengchuan Dai
Journal:  Int Urol Nephrol       Date:  2011-11-25       Impact factor: 2.370

5.  Modulating influence of cytochrome P-450 MspI polymorphism on serum liver function profiles in coke oven workers.

Authors:  M T Wu; C K Ho; S L Huang; Y F Yeh; C L Liu; I F Mao; D C Christiani
Journal:  Occup Environ Med       Date:  1999-03       Impact factor: 4.402

6.  Variation in genes relevant to aromatic hydrocarbon metabolism and the risk of adult brain tumors.

Authors:  Anneclaire J De Roos; Nathaniel Rothman; Merideth Brown; Douglas A Bell; Gary S Pittman; William R Shapiro; Robert G Selker; Howard A Fine; Peter M Black; Peter D Inskip
Journal:  Neuro Oncol       Date:  2006-01-27       Impact factor: 12.300

7.  Association of CYP1A1 Gene Polymorphism with Ischemic Stroke in South Indian Population.

Authors:  Shehnaz Sultana; Venkata Karunakar Kolla; Vidyullatha Peddireddy; Yasovanthi Jeedigunta; Pranay K Penagaluru; Sindhu Joshi; Usha Rani Penagaluru; Pardhananda Reddy Penagaluru
Journal:  Transl Stroke Res       Date:  2011-01-20       Impact factor: 6.829

8.  The association of CYP1A1 genetic polymorphisms and additional gene-gene interaction with ischemic stroke in the eastern Han of China.

Authors:  Meng Zhang; Jian-Ming Wu; Qiu-Sheng Zhang; Da-Wei Yan; Li-Jie Ren; Wei-Ping Li
Journal:  Neurol Sci       Date:  2016-07-06       Impact factor: 3.307

Review 9.  Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention.

Authors:  Vasilis P Androutsopoulos; Aristidis M Tsatsakis; Demetrios A Spandidos
Journal:  BMC Cancer       Date:  2009-06-16       Impact factor: 4.430

10.  Meta-analysis and pooled analysis of GSTM1 and CYP1A1 polymorphisms and oral and pharyngeal cancers: a HuGE-GSEC review.

Authors:  Leonor Varela-Lema; Emanuela Taioli; Alberto Ruano-Ravina; Juan M Barros-Dios; Devasena Anantharaman; Simone Benhamou; Stefania Boccia; Rajani A Bhisey; Gabriella Cadoni; Ettore Capoluongo; Chien-Jen Chen; William Foulkes; Eny Maria Goloni-Bertollo; Ana Hatagima; Richard B Hayes; Takahiko Katoh; Sergio Koifman; Phillip Lazarus; Johannes J Manni; Manoj Mahimkar; Shunji Morita; Jong Park; Kwang-Kyun Park; Erika Cristina Pavarino Bertelli; Enilze Maria de Souza Fonseca Ribeiro; Bidyut Roy; Margaret R Spitz; Richard C Strange; Qingyi Wei; Camille C Ragin
Journal:  Genet Med       Date:  2008-06       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.